FATE director exercises options for 25,000 shares

FATE Therapeutics director William H. Rastetter exercised stock options to acquire 25,000 shares of Common Stock at $1.69 per share.

Rhea-AI Filing Summary

FATE Therapeutics director William H. Rastetter exercised stock options to acquire 25,000 shares of Common Stock at $1.69 per share. Following the exercise, he holds 36,331 Common shares directly. In addition, 459,272 shares are held indirectly by The Investment 2002 Trust and 146,821 shares are held indirectly by The Rastetter Family Trust, where he serves in trustee roles.

Insider Trade Summary

25,000 shares exercised/converted

Exercise 4 txns

Insider RASTETTER WILLIAM H

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	25,000	$0.00	$0.00
Exercise	Common Stock	25,000	$1.69	$42K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 36,331 shares (Direct); Common Stock — 146,821 shares (Indirect, By The Rastetter Family Trust, dated 09/02/10); Common Stock — 459,272 shares (Indirect, By The Investment 2002 Trust, dated 11/11/02)

Footnotes (3)

1. F1. These shares are owned of record by The Rastetter Family Trust, dated September 2, 2010 for which William H. Rastetter and Marisa Gard Rastetter serve as co-trustees.
2. F2. These shares are owned of record by The Investment Trust, dated November 11, 2002, for which William H. Rastetter is the sole trustee and owner.
3. F3. The shares subject to the option vested and became exercisable on the date of the 2017 Annual Meeting of Stockholders.

Key Figures

Option exercise shares: 25,000 shares Exercise price: $1.69 per share Direct common shares after transaction: 36,331 shares +3 more

6 metrics

Option exercise shares 25,000 shares Common Stock acquired via option exercise on 2026-05-05

Exercise price $1.69 per share Conversion or exercise price for 25,000-share option

Direct common shares after transaction 36,331 shares Direct ownership following the option exercise

Investment 2002 Trust holdings 459,272 shares Indirect ownership by The Investment 2002 Trust

Rastetter Family Trust holdings 146,821 shares Indirect ownership by The Rastetter Family Trust

Exercise count 1 transaction Derivative exercise or conversion events in this filing

Key Terms

Stock Option (Right to Buy), derivative security, indirect ownership, co-trustees

4 terms

Stock Option (Right to Buy) financial

"security_title": "Stock Option (Right to Buy)""

derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

indirect ownership financial

"ownership_type": "indirect""

co-trustees financial

"serve as co-trustees."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FATE (FATE Therapeutics) report for William H. Rastetter?

FATE reported that director William H. Rastetter exercised stock options for 25,000 shares. He converted options into common stock at $1.69 per share, increasing his directly held common shares while not reporting any open-market sales in this filing.

At what price did William H. Rastetter exercise FATE stock options?

Rastetter exercised his FATE stock options at $1.69 per share. The Form 4 shows an option exercise of 25,000 shares with a conversion or exercise price of $1.69, turning those derivative securities into directly held common stock.

How many FATE shares does William H. Rastetter hold directly after this Form 4?

After the reported transactions, Rastetter directly holds 36,331 FATE common shares. This figure reflects his position following the 25,000-share option exercise, with no remaining stock options of that series outstanding after the transaction.

What indirect FATE shareholdings are reported for William H. Rastetter?

The filing lists 459,272 FATE shares held by The Investment 2002 Trust and 146,821 shares by The Rastetter Family Trust. These positions are reported as indirect ownership, with Rastetter serving as trustee or co-trustee for the respective trusts.

Did the FATE Form 4 show any stock sales by William H. Rastetter?

The Form 4 does not report any sales of FATE shares by Rastetter. It shows an option exercise coded “M” for 25,000 shares and updated holdings, but no transactions marked as open-market sales or dispositions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/06/2026 - 04:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RASTETTER WILLIAM H

(Last) (First) (Middle)

C/O FATE THERAPEUTICS, INC.

12278 SCRIPPS SUMMIT DRIVE

(Street)

SAN DIEGO CALIFORNIA 92131

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FATE THERAPEUTICS INC [ FATE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/05/2026		M		25,000	A	$1.69	36,331	D
Common Stock								146,821	I	By The Rastetter Family Trust, dated 09/02/10(1)
Common Stock								459,272	I	By The Investment 2002 Trust, dated 11/11/02(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.69	05/05/2026		M		25,000		(3)	05/11/2026	Common Stock	25,000	$0.00	0	D

Explanation of Responses:

1. These shares are owned of record by The Rastetter Family Trust, dated September 2, 2010 for which William H. Rastetter and Marisa Gard Rastetter serve as co-trustees.

2. These shares are owned of record by The Investment Trust, dated November 11, 2002, for which William H. Rastetter is the sole trustee and owner.

3. The shares subject to the option vested and became exercisable on the date of the 2017 Annual Meeting of Stockholders.

	/s/ Cindy Tahl, as Attorney-in-Fact	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)